US Stock MarketDetailed Quotes
GALT Galectin Therapeutics
- 2.500
- -0.195-7.24%
Close Sep 3 16:00 ET
- 2.500
- 0.0000.00%
Post 16:02 ET
155.70MMarket Cap-3205P/E (TTM)
2.648High2.500Low125.27KVolume2.640Open2.695Pre Close320.18KTurnover0.29%Turnover RatioLossP/E (Static)62.28MShares4.26852wk High-1.85P/B107.79MFloat Cap1.55552wk Low--Dividend TTM43.11MShs Float38.280Historical High--Div YieldTTM5.47%Amplitude0.300Historical Low2.555Avg Price1Lot Size
Galectin Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 25.41%11.29M | -6.71%9.65M | -0.73%38.07M | -10.08%9.56M | 12.85%9.17M | -6.82%9M | 4.10%10.34M | 27.08%38.35M | 43.21%10.63M | -1.48%8.12M |
| Selling and administrative expenses | -9.44%1.48M | 3.31%1.59M | -10.17%5.94M | -18.02%1.33M | -5.91%1.43M | 2.77%1.63M | -17.79%1.54M | 3.99%6.62M | 3.63%1.63M | -6.56%1.52M |
| -General and administrative expense | -9.44%1.48M | 3.31%1.59M | -10.17%5.94M | -18.02%1.33M | -5.91%1.43M | 2.77%1.63M | -17.79%1.54M | 3.99%6.62M | 3.63%1.63M | -6.56%1.52M |
| Research and development costs | 33.13%9.81M | -8.47%8.05M | 1.24%32.13M | -8.65%8.23M | 17.19%7.73M | -8.71%7.37M | 9.20%8.8M | 33.25%31.74M | 53.81%9.01M | -0.23%6.6M |
| Operating profit | -25.41%-11.29M | 6.71%-9.65M | 0.73%-38.07M | 10.08%-9.56M | -12.85%-9.17M | 6.82%-9M | -4.10%-10.34M | -27.08%-38.35M | -43.21%-10.63M | 1.48%-8.12M |
| Net non-operating interest income expense | -98.17%-1.19M | -133.65%-972K | -161.16%-2.56M | -178.06%-773K | -207.97%-773K | -165.49%-600K | -84.07%-416K | -101.85%-981K | -2.21%-278K | -128.18%-251K |
| Non-operating interest income | 60.00%80K | 81.82%80K | 342.31%230K | 146.67%74K | 244.44%62K | 1,566.67%50K | 4,300.00%44K | 1,633.33%52K | --30K | 1,700.00%18K |
| Non-operating interest expense | 95.23%1.27M | 128.70%1.05M | 170.28%2.79M | 175.00%847K | 210.41%835K | 183.84%650K | 102.64%460K | 111.25%1.03M | 13.24%308K | 142.34%269K |
| Other net income (expense) | -77.71%109K | -13.00%-869K | -177.56%-432K | 21.66%337K | -118.30%-489K | 77.82%489K | -435.81%-769K | 303.62%557K | -41.81%277K | -34.94%-224K |
| Gain on sale of security | -77.71%109K | -13.00%-869K | -177.56%-432K | 21.66%337K | -118.30%-489K | 77.82%489K | -435.81%-769K | 303.62%557K | -41.81%277K | -34.94%-224K |
| Income before tax | -35.74%-12.37M | 0.33%-11.49M | -5.91%-41.07M | 5.99%-10M | -21.30%-10.43M | 5.19%-9.11M | -16.06%-11.53M | -27.02%-38.78M | -47.26%-10.63M | -0.90%-8.6M |
| Income tax | ||||||||||
| Net income | -35.74%-12.37M | 0.33%-11.49M | -5.91%-41.07M | 5.99%-10M | -21.30%-10.43M | 5.19%-9.11M | -16.06%-11.53M | -27.02%-38.78M | -47.26%-10.63M | -0.90%-8.6M |
| Net income continuous Operations | -35.74%-12.37M | 0.33%-11.49M | -5.91%-41.07M | 5.99%-10M | -21.30%-10.43M | 5.19%-9.11M | -16.06%-11.53M | -27.02%-38.78M | -47.26%-10.63M | -0.90%-8.6M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -35.74%-12.37M | 0.33%-11.49M | -5.91%-41.07M | 5.99%-10M | -21.30%-10.43M | 5.19%-9.11M | -16.06%-11.53M | -27.02%-38.78M | -47.26%-10.63M | -0.90%-8.6M |
| Preferred stock dividends | 1.59%64K | 8K | 23.71%120K | -3.08%63K | 62.50%-6K | -1.56%63K | -43.27%97K | -2.99%65K | -143.24%-16K | |
| Other preferred stock dividends | 3.62M | 0 | 3.62M | 0 | 0 | 0 | ||||
| Net income attributable to common stockholders | -35.50%-12.44M | 0.26%-11.5M | -15.26%-44.81M | 5.97%-10.06M | -63.63%-14.04M | 5.17%-9.18M | -16.25%-11.53M | -26.63%-38.87M | -46.80%-10.7M | -0.28%-8.58M |
| Basic earnings per share | -33.33%-0.2 | 0.00%-0.19 | -13.85%-0.74 | 11.11%-0.16 | -71.43%-0.24 | 6.25%-0.15 | -11.76%-0.19 | -25.00%-0.65 | -50.00%-0.18 | 0.00%-0.14 |
| Diluted earnings per share | -33.33%-0.2 | 0.00%-0.19 | -13.85%-0.74 | 11.11%-0.16 | -71.43%-0.24 | 6.25%-0.15 | -11.76%-0.19 | -25.00%-0.65 | -50.00%-0.18 | 0.00%-0.14 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg